{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:59:08Z","timestamp":1772150348931,"version":"3.50.1"},"reference-count":32,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,18]],"date-time":"2025-03-18T00:00:00Z","timestamp":1742256000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thegreenjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Radiotherapy and Oncology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/j.radonc.2025.110851","type":"journal-article","created":{"date-parts":[[2025,3,19]],"date-time":"2025-03-19T17:31:16Z","timestamp":1742405476000},"page":"110851","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["The prognostic and predictive value of pre-treatment hematologic markers for oropharyngeal carcinoma stratified by HPV status and treated with definitive (chemo) radiation"],"prefix":"10.1016","volume":"207","author":[{"given":"A.","family":"Hughes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ca","family":"Johnny","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"SH.","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Su","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Bratman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Cho","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Hahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hosni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Hope","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B.","family":"O\u2019Sullivan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JG.","family":"Ringash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Waldron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Spreafico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.Sanz","family":"Garcia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"DeAlmeida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Tong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"McPartlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.radonc.2025.110851_b0005","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0140-6736(18)32752-1","article-title":"Radiotherapy plus cisplatin or cetuximab in low-risk human papillomavirus-positive oropharyngeal cancer (De-ESCALaTE HPV): an open-label randomised controlled phase 3 trial","volume":"393","author":"Mehanna","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/j.radonc.2025.110851_b0010","doi-asserted-by":"crossref","first-page":"3582","DOI":"10.1200\/JCO.2007.14.8841","article-title":"Factors associated with severe late toxicity after concurrent chemoradiation for locally advanced head and neck cancer: An RTOG analysis","volume":"26","author":"Machtay","year":"2008","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2025.110851_b0015","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2020.105140","article-title":"Improved survival prediction for oropharyngeal cancer beyond TNMv8","volume":"115","author":"Price","year":"2021","journal-title":"Oral Oncol."},{"key":"10.1016\/j.radonc.2025.110851_b0020","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105620","article-title":"De-escalation studies in HPV-positive oropharyngeal cancer: How should we proceed?","volume":"123","author":"Golusinski","year":"2021","journal-title":"Oral Oncol."},{"key":"10.1016\/j.radonc.2025.110851_b0025","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1158\/1541-7786.MCR-04-0032","article-title":"Cisplatin Sensitizes Cancer Cells to Ionizing Radiation via Inhibition of Nonhomologous End Joining","volume":"3","author":"Boeckman","year":"2005","journal-title":"Mol. Cancer Res."},{"key":"10.1016\/j.radonc.2025.110851_b0030","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1038\/s41590-021-01120-y","article-title":"Recruitment and activation of type 3 innate lymphoid cells promote antitumor immune responses","volume":"23","author":"Bruchard","year":"2022","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.radonc.2025.110851_b0035","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1002\/ijc.33876","article-title":"Treatment outcomes and survival following definitive (chemo)radiotherapy in HPV-positive oropharynx cancer: Large-scale comparison of DAHANCA vs PMH cohorts","volume":"150","author":"Lassen","year":"2022","journal-title":"Int. J. Cancer"},{"key":"10.1016\/j.radonc.2025.110851_b0040","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.radonc.2021.01.013","article-title":"Meta-analysis of chemotherapy in head and neck cancer (MACH-NC): An update on 107 randomized trials and 19,805 patients, on behalf of MACH-NC Group","volume":"156","author":"Lacas","year":"2021","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2025.110851_b0045","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1016\/j.ijrobp.2024.08.014","article-title":"Interim Futility Results of NRG-HN005, A Randomized, Phase II\/III Non-Inferiority Trial for Non-Smoking p16+ Oropharyngeal Cancer Patients","volume":"120","author":"Yom","year":"2024","journal-title":"International Journal of Radiation Oncology*Biology*Physics"},{"key":"10.1016\/j.radonc.2025.110851_b0050","doi-asserted-by":"crossref","DOI":"10.1016\/j.oraloncology.2021.105245","article-title":"Pre-treatment absolute lymphocyte count predicts for improved survival in human papillomavirus (HPV)-driven oropharyngeal squamous cell carcinoma","volume":"116","author":"Kreinbrink","year":"2021","journal-title":"Oral Oncol."},{"key":"10.1016\/j.radonc.2025.110851_b0055","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/s41416-020-01106-x","article-title":"Prognostic significance of pre-treatment neutrophil-to-lymphocyte ratio (NLR) in patients with oropharyngeal cancer treated with radiotherapy","volume":"124","author":"Ng","year":"2021","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.radonc.2025.110851_b0060","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1007\/s11864-023-01050-x","article-title":"Immunotherapy in HPV-Related Oropharyngeal Cancers","volume":"24","author":"Roof","year":"2023","journal-title":"Curr. Treat. Options Oncol."},{"key":"10.1016\/j.radonc.2025.110851_b0065","doi-asserted-by":"crossref","first-page":"S557","DOI":"10.1016\/j.annonc.2023.09.2002","article-title":"856MO A randomized phase II study of concurrent vs. sequential pembrolizumab with chemoradiation (CRT) in locally advanced head and neck cancer (LA HNSCC): 4-year results and tumor-immune microenvironment analysis","volume":"34","author":"Zandberg","year":"2023","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.radonc.2025.110851_b0070","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1200\/JCO.21.01991","article-title":"Pretreatment Lymphocyte Count Predicts Benefit From Concurrent Chemotherapy With Radiotherapy in Oropharyngeal Cancer","volume":"40","author":"Price","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.radonc.2025.110851_b0075","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1002\/cncr.29100","article-title":"Prognostic value of pretreatment circulating neutrophils, monocytes, and lymphocytes in oropharyngeal cancer stratified by human papillomavirus status","volume":"121","author":"Huang","year":"2015","journal-title":"Cancer"},{"key":"10.1016\/j.radonc.2025.110851_b0080","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/hed.24986","article-title":"Prognostic role of neutrophil-to-lymphocyte ratio in head and neck cancer: A meta-analysis","volume":"40","author":"Takenaka","year":"2018","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2025.110851_b0085","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.1002\/hed.25625","article-title":"Prognostic significance and population dynamics of peripheral monocytes in patients with oropharyngeal squamous cell carcinoma","volume":"41","author":"Takahashi","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2025.110851_b0090","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.radonc.2010.03.015","article-title":"Point-of-care outcome assessment in the cancer clinic: Audit of data quality","volume":"95","author":"Wong","year":"2010","journal-title":"Radiother. Oncol."},{"key":"10.1016\/j.radonc.2025.110851_b0095","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0167-9473(98)00096-6","article-title":"An application of changepoint methods in studying the effect of age on survival in breast cancer","volume":"30","author":"Contal","year":"1999","journal-title":"Computational Statistics and Data Analysis"},{"key":"10.1016\/j.radonc.2025.110851_b0100","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1038\/bjc.2013.639","article-title":"Tumour-infiltrating lymphocytes predict for outcome in HPV-positive oropharyngeal cancer","volume":"110","author":"Ward","year":"2014","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.radonc.2025.110851_b0105","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1245\/s10434-011-1906-x","article-title":"The immunological impact of neoadjuvant chemotherapy on the tumor microenvironment of esophageal squamous cell carcinoma","volume":"19","author":"Tsuchikawa","year":"2012","journal-title":"Ann. Surg. Oncol."},{"key":"10.1016\/j.radonc.2025.110851_b0110","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1158\/2326-6066.CIR-17-0235","article-title":"Cisplatin alters antitumor immunity and synergizes with PD-1\/PD-L1 inhibition in head and neck squamous cell carcinoma","volume":"5","author":"Tran","year":"2017","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.radonc.2025.110851_b0115","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1158\/1078-0432.CCR-05-1761","article-title":"Combination chemotherapy and radiation of human squamous cell carcinoma of the head and neck augments CTL-mediated lysis","volume":"12","author":"Gelbard","year":"2006","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.radonc.2025.110851_b0120","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1111\/odi.13366","article-title":"Prognostic significance of neutrophil-to-lymphocyte ratio in HPV status era for oropharyngeal cancer","volume":"26","author":"Fanetti","year":"2020","journal-title":"Oral Dis."},{"key":"10.1016\/j.radonc.2025.110851_b0125","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.pvr.2017.12.002","article-title":"Anemia and neutrophil-to-lymphocyte ratio are prognostic in p16-positive oropharyngeal carcinoma treated with concurrent chemoradiation","volume":"5","author":"Gorphe","year":"2018","journal-title":"Papillomavirus Research"},{"key":"10.1016\/j.radonc.2025.110851_b0130","doi-asserted-by":"crossref","DOI":"10.3390\/v15010198","article-title":"Pretreatment Neutrophil-to-Lymphocyte Ratio as a Prognostic Marker for the Outcome of HPV-Positive and HPV-Negative Oropharyngeal Squamous Cell Carcinoma","volume":"15","author":"Justesen","year":"2023","journal-title":"Viruses"},{"key":"10.1016\/j.radonc.2025.110851_b0135","doi-asserted-by":"crossref","DOI":"10.1186\/s12967-017-1268-7","article-title":"Survival impact of pre-treatment neutrophils on oropharyngeal and laryngeal cancer patients undergoing definitive radiotherapy","volume":"15","author":"Sumner","year":"2017","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.radonc.2025.110851_b0140","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/0194599818764651","article-title":"Prognostic Role of Neutrophil-to-Lymphocyte Ratio in Patients with Human Papillomavirus\u2013Positive Oropharyngeal Cancer","volume":"159","author":"So","year":"2018","journal-title":"Otolaryngology - Head and Neck Surgery (United States)"},{"key":"10.1016\/j.radonc.2025.110851_b0145","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/hed.24576","article-title":"Pretreatment lymphocyte-to-monocyte ratio as an independent prognostic factor for head and neck cancer","volume":"39","author":"Kano","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/j.radonc.2025.110851_b0150","doi-asserted-by":"crossref","first-page":"7074","DOI":"10.3390\/curroncol31110521","article-title":"The Prognostic Role of Pre-Treatment Neutrophil-to-Lymphocyte Ratio in an Asian Cohort of Patients with Oropharyngeal Squamous Cell Carcinoma","volume":"31","author":"Jang","year":"2024","journal-title":"Curr. Oncol."},{"key":"10.1016\/j.radonc.2025.110851_b0155","first-page":"8","article-title":"Prognostic significance of the neutrophil\/lymphocyte ratio in patients with non-human papilloma virus-related oropharyngeal cancer: A retrospective cohort study","volume":"96","author":"De Felice","year":"2018","journal-title":"Oncology (Switzerland)"},{"key":"10.1016\/j.radonc.2025.110851_b0160","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-017-3590-0","article-title":"Neutrophil-lymphocyte ratio complements volumetric staging as prognostic factor in patients treated with definitive radiotherapy for oropharyngeal cancer","volume":"17","author":"Panje","year":"2017","journal-title":"BMC Cancer"}],"container-title":["Radiotherapy and Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402500146X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016781402500146X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T11:40:31Z","timestamp":1762256431000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016781402500146X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,6]]},"references-count":32,"alternative-id":["S016781402500146X"],"URL":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110851","relation":{},"ISSN":["0167-8140"],"issn-type":[{"value":"0167-8140","type":"print"}],"subject":[],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The prognostic and predictive value of pre-treatment hematologic markers for oropharyngeal carcinoma stratified by HPV status and treated with definitive (chemo) radiation","name":"articletitle","label":"Article Title"},{"value":"Radiotherapy and Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.radonc.2025.110851","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"110851"}}